A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART

NCT01378156 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1 Infection

Interventions

BIOLOGICAL: JS7 plasmid DNA and MVA62B vaccine

Sponsor

GeoVax, Inc.

Collaborators

[object Object]
[object Object]
[object Object]